| 1 | = | Malignant Breast Neoplasm | 251,791 | 100 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1667
- siteDefinition
- USCS "Female Breast" (ICD-10 C50; ICD-O-3 C500-C509)
ranking row 2601606 |
| 2 | = | Malignant Lung Neoplasm | 108,889 | 96.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3755
- siteDefinition
- USCS "Lung and Bronchus" (ICD-10 C34; ICD-O-3 C340-C349)
ranking row 2601607 |
| 3 | = | Malignant Uterine Corpus Neoplasm | 55,942 | 92.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1157
- siteDefinition
- USCS "Corpus" (ICD-10 C54; ICD-O-3 C540-C549)
ranking row 2601608 |
| 4 | = | Malignant Colon Neoplasm | 52,038 | 89.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 851
- siteDefinition
- USCS "Colon excluding Rectum" (ICD-10 C18, C26.0; ICD-O-3 C180-C189, C260)
ranking row 2601609 |
| 5 | = | Malignant Thyroid Gland Neoplasm | 36,542 | 85.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7019
- siteDefinition
- USCS "Thyroid" (ICD-10 C73; ICD-O-3 C739)
ranking row 2601610 |
| 6 | = | Cutaneous Melanoma | 34,808 | 82.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4061
- siteDefinition
- USCS "Melanomas of the Skin" (ICD-10 C43; ICD-O-3 C440-C449 with histology 8720-8790)
ranking row 2601611 |
| 7 | = | Non-Hodgkin Lymphoma | 33,072 | 78.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5285
- siteDefinition
- USCS "Non-Hodgkin Lymphoma" (ICD-10 C82-C85, C96.3; ICD-O-3 histology 9590-9597, 9670-9729, 9735, 9737-9738 (+9811-9818, 9823, 9827, 9837 outside marrow/blood))
ranking row 2601612 |
| 8 | = | Malignant Pancreatic Neoplasm | 24,634 | 75 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5795
- siteDefinition
- USCS "Pancreas" (ICD-10 C25; ICD-O-3 C250-C259)
ranking row 2601613 |
| 9 | = | Malignant Kidney Neoplasm | 24,142 | 71.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2531
- siteDefinition
- USCS "Kidney and Renal Pelvis" (ICD-10 C64-C65; ICD-O-3 C649, C659)
ranking row 2601614 |
| 10 | = | Leukemia | 22,636 | 67.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3143
- siteDefinition
- USCS "Leukemias" (ICD-10 C91-C95 (leukemia recodes; C90.1 plasma cell leukemia included by SEER); ICD-O-3 leukemia histologies 9733-9948 per SEER site recode)
ranking row 2601615 |
| 11 | = | Malignant Ovarian Neoplasm | 21,388 | 64.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 5591
- siteDefinition
- USCS "Ovary" (ICD-10 C56; ICD-O-3 C569)
ranking row 2601616 |
| 12 | = | Malignant Bladder Neoplasm | 18,408 | 60.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7325
- siteDefinition
- USCS "Urinary Bladder" (ICD-10 C67; ICD-O-3 C670-C679)
ranking row 2601617 |
| 13 | = | Malignant Rectal Neoplasm | 17,490 | 57.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6101
- siteDefinition
- USCS "Rectum and Rectosigmoid Junction" (ICD-10 C19-C20; ICD-O-3 C199, C209)
ranking row 2601618 |
| 14 | = | Malignant Cervical Neoplasm | 13,409 | 53.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 647
- siteDefinition
- USCS "Cervix" (ICD-10 C53; ICD-O-3 C530-C539)
ranking row 2601619 |
| 15 | = | Multiple Myeloma | 12,490 | 50 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4673
- siteDefinition
- USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734)
ranking row 2601620 |
| 16 | = | Malignant Central Nervous System Neoplasm | 10,284 | 46.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 341
- siteDefinition
- USCS "Brain and Other Nervous System" (ICD-10 C70, C71, C72; ICD-O-3 C700-C709, C710-C719, C720-C729)
ranking row 2601621 |
| 17 | = | Malignant Liver Neoplasm | 10,045 | 42.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 3449
- siteDefinition
- USCS "Liver and Intrahepatic Bile Duct" (ICD-10 C22; ICD-O-3 C220-C221)
ranking row 2601622 |
| 18 | = | Malignant Gastric Neoplasm | 9,634 | 39.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6713
- siteDefinition
- USCS "Stomach" (ICD-10 C16; ICD-O-3 C160-C169)
ranking row 2601623 |
| 19 | = | Malignant Vulvar Neoplasm | 5,358 | 35.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7835
- siteDefinition
- USCS "Vulva" (ICD-10 C51; ICD-O-3 C510-C519)
ranking row 2601624 |
| 20 | = | Malignant Anal Neoplasm | 5,090 | 32.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 35
- siteDefinition
- USCS "Anus, Anal Canal and Anorectum" (ICD-10 C21; ICD-O-3 C210-C212, C218)
ranking row 2601625 |
| 21 | = | Hodgkin Lymphoma | 3,937 | 28.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1769
- siteDefinition
- USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal))
ranking row 2601626 |
| 22 | = | Malignant Esophageal Neoplasm | 3,784 | 25 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 1361
- siteDefinition
- USCS "Esophagus" (ICD-10 C15; ICD-O-3 C150-C159)
ranking row 2601627 |
| 23 | = | Malignant Laryngeal Neoplasm | 2,590 | 21.4 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2837
- siteDefinition
- USCS "Larynx" (ICD-10 C32; ICD-O-3 C320-C329)
ranking row 2601628 |
| 24 | = | Malignant Salivary Gland Neoplasm | 1,974 | 17.9 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 6407
- siteDefinition
- USCS "Salivary Gland" (ICD-10 C07-C08; ICD-O-3 C079-C089)
ranking row 2601629 |
| 25 | = | Malignant Vaginal Neoplasm | 1,345 | 14.3 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 7631
- siteDefinition
- USCS "Vagina" (ICD-10 C52; ICD-O-3 C529)
ranking row 2601630 |
| 26 | = | Malignant Mesothelioma | 800 | 10.7 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4367
- siteDefinition
- USCS "Mesothelioma" (ICD-10 C45; ICD-O-3 histology 9050-9055 (any site))
ranking row 2601631 |
| 27 | = | Malignant Nasopharyngeal Neoplasm | 545 | 7.1 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 4979
- siteDefinition
- USCS "Nasopharynx" (ICD-10 C11; ICD-O-3 C110-C119)
ranking row 2601632 |
| 28 | = | Malignant Hypopharyngeal Neoplasm | 481 | 3.6 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2075
- siteDefinition
- USCS "Hypopharynx" (ICD-10 C12-C13; ICD-O-3 C129, C130-C139)
ranking row 2601633 |
| 29 | = | Kaposi Sarcoma | 123 | 0 | High confidence | cdc-uscs | inputs- sourceId
- CI-SOURCE-00000012
- estimateType
- observed
- observationId
- 2381
- siteDefinition
- USCS "Kaposi Sarcoma" (ICD-10 C46; ICD-O-3 histology 9140 (any site))
ranking row 2601634 |